… are the recent advances in the diagnosis and treatment of neonatal abstinence syndrome? …
developed to assess and diagnose neonatal abstinence syndrome objectively, but none are …

… Prolonged in utero drug exposure may result in neonatal abstinence syndrome ( NAS ), an
acute multisystemic clinical entity that occurs in the first days of life. This syndrome is caused …

… Many of the other abstinence syndrome assessment tools produce scores that may be
considered subjective and represent only a one-time snapshot of the infants’ overall condition, …

… work describing neonatal abstinence syndrome (NAS) as a … to advance standardization of
health care provider reporting. … clinical diagnosis of NAS/NOWS (neonatal opioid withdrawal …

… This continuum was codified in 1987 by specific diagnostic criteria in the diagnostic manual
… after the acute withdrawal syndrome has ended. Protracted abstinence consisting of subtle …

… to neonatal abstinence syndrome severity and clinical course. … abstinence syndrome rates
per 1,000 births by race/ethnicity, 2015 (Q1-Q3). Secondary neonatal abstinence syndrome …

… advancement in the last decade has enabled more sophisticated and objective platforms for
the diagnosis of … Such advancement is key to the systematic understanding and prediction of …

… The increase in opioid use among the general population is reflected in pregnant women
and neonatal abstinence syndrome (NAS) statistics. This increase has produced an …

… contributing to the difficulty in its diagnosis and management. Most babies … Although NAS is
diagnosed clinically other possible … Placental transmission increases as gestation advances. …

… Advances in our knowledge about NAS signs and symptoms, paired with advances in
measurement theory, should allow us to develop better measures of NAS. A measure that limits its …